HBP.TO
Helix Biopharma Corp
Price:  
0.19 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO Intrinsic Value

-199.59 %
Upside

As of 2024-03-01, the Intrinsic Value of Helix Biopharma Corp (HBP.TO) is -0.18 CAD. This HBP.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.19 CAD, the upside of Helix Biopharma Corp is -199.59%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.19 CAD
Stock Price
-0.18 CAD
Intrinsic Value
Intrinsic Value Details

HBP.TO Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -0.18 - -0.18 -0.18 -199.59%
DDM - Stable (0.27) - (3.15) (1.71) -1026.2%
DDM - Multi (0.20) - (1.96) (0.37) -302.6%

HBP.TO Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 40.08
Beta 1.00
Outstanding shares (mil) 216.67
Enterprise Value (mil) 38.44
Market risk premium 5.10%
Cost of Equity 8.96%
Cost of Debt 5.00%
WACC 6.33%